Pfizer’s Revatio flunks paediatric hypertension studyAn attempt by Pfizer to extend the uses of its pulmonary artery hypertension (PAH) drug Revatio into a Share XPfizer’s Revatio flunks paediatric hypertension studyhttps://pharmaphorum.com/news/pfizers-revatio-flunks-paediatric-hypertension-study/
Improving Access to Innovative Paediatric MedicinesPaediatric Clinical Trials Share XImproving Access to Innovative Paediatric Medicineshttps://pharmaphorum.com/partner-content-patients/improving-access-to-innovative-paediatric-medicines/
Brexit could deny children access to cancer drug trialsExperts call for shake-up of EU regulation. Share XBrexit could deny children access to cancer drug trialshttps://pharmaphorum.com/news/brexit-deny-children-access-cancer-drug-trials/